Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant in children with narcolepsy (double-blind then open-label)
2024-515568-30-00Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2) comparing Pitolisant arm with Placebo arm (2 arms). Primary endpoint: Change in Ullanlinna Narcolepsy Scale (UNS) score. Started Dec 2024; status: completed.
02
Drugs
pitolisant
03
Conditions
narcolepsy type 1 (NT1)narcolepsy type 2 (NT2)
Beyond the preview
Go deeper on 2024-515568-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515568-30-00.